Parasite and Host Biology Group, ICMR-National Institute of Malaria Research, Dwarka, Sector 8, New Delhi, 110077, India.
Infection. 2023 Jun;51(3):623-640. doi: 10.1007/s15010-022-01952-2. Epub 2022 Nov 19.
Plasmodium cynomolgi (Pcy), a simian malaria parasite, is a recent perfect example of emerging zoonotic transfer in human. This review summarizes the current knowledge on the epidemiology of natural Pcy infections in humans, mosquitoes and monkeys, along with its biological, clinical and drug sensitivity patterns. Knowledge gaps and further studies on Pcy in humans are also discussed. This parasite currently seems to be geographically limited in South-East Asia (SEA) with a global prevalence in human ranging from 0 to 1.4%. The Pcy infections were reported in local SEA populations and European travelers, and range from asymptomatic carriage to mild/moderate attacks with no evidence of pathognomonic clinical and laboratory patterns but with Pcy strain-shaped clinical differences. Geographical distribution and competence of suitable mosquito vectors and non-primate hosts, globalization, climate change, and increased intrusion of humans into the habitat of monkeys are key determinants to emergence of Pcy parasites in humans, along with its expansion outside SEA. Sensitization/information campaigns coupled with training and assessment sessions of microscopists and clinicians on Pcy are greatly needed to improve data on the epidemiology and management of human Pcy infection. There is a need for development of sensitive and specific molecular tools for individual diagnosis and epidemiological studies. The development of safe and efficient anti-hypnozoite drugs is the main therapeutic challenge for controlling human relapsing malaria parasites. Experience gained from P. knowlesi malaria, development of integrated measures and strategies-ideally with components related to human, monkeys, mosquito vectors, and environment-could be very helpful to prevent emergence of Pcy malaria in humans through disruption of transmission chain from monkeys to humans and ultimately contain its expansion in SEA and potential outbreaks in a context of malaria elimination.
食蟹猴疟原虫(Pcy)是一种灵长类疟原虫,是人类中新兴人畜共患病转移的最近完美范例。本综述总结了目前关于人类、蚊子和猴子中自然感染 Pcy 的流行病学、生物学、临床和药物敏感性模式的知识。还讨论了人类 Pcy 的知识空白和进一步研究。该寄生虫目前在东南亚(SEA)地区似乎具有地域局限性,全球范围内人类的流行率从 0 到 1.4%不等。在当地的东南亚人群和欧洲旅行者中报告了 Pcy 感染,从无症状携带到轻度/中度发作不等,没有明显的特征性临床和实验室模式,但存在与 Pcy 株形临床差异。地理分布和合适的蚊子媒介和非灵长类宿主的能力、全球化、气候变化以及人类对猴子栖息地的入侵增加,是 Pcy 寄生虫在人类中出现以及在 SEA 以外地区扩张的关键决定因素。需要开展宣传/信息宣传活动,并对显微镜检查者和临床医生进行关于 Pcy 的培训和评估,以改善有关人类 Pcy 感染的流行病学和管理的数据。需要开发用于个体诊断和流行病学研究的敏感和特异的分子工具。开发安全有效的抗休眠子药物是控制人类复发性疟疾寄生虫的主要治疗挑战。从间日疟原虫获得的经验,制定综合措施和策略-理想情况下与人类、猴子、蚊子媒介和环境有关的组成部分-可以通过破坏从猴子到人类的传播链,防止人类食蟹猴疟的出现,并最终在消除疟疾的背景下遏制其在 SEA 的扩张和潜在爆发。